CrossAssetDataThe Company File
···
IRTC

iRhythm Holdings, Inc.

iRhythm Holdings, Inc. is classed by the SEC under Surgical & Medical Instruments & Apparatus (industry code 3841), based in San Francisco, CA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $747 million and a loss of $45 million (its filed statements).

Product business Surgical & Medical Instruments & Apparatus San Francisco, CA filings since 2007 9 of 9 filed
Ask the desk about IRTC → Compare IRTC with EMBC → Price chart on TradingView ↗ Full EDGAR file ↗ Watch IRTC →

Sector peers: EMBCINSPGKOSAORT

5.8/10headline grade
vs its business-model standard
5.4/10past 5.5/10present 6.5/10future

Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a product business: prior from its industry code (SEC 3841, Surgical & Medical Instruments & Apparatus); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.

The grade, in three tenses

Headline 5.8 out of ten, 9 of 9 metrics filed: past 5.4 out of ten, present 5.5 out of ten, future 6.5 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.

The nine metrics

  • Surviving crises (past): 2.5 out of ten. 5 warning events since 2017; the latest 2026-06-15. 25th percentile among 121 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Track record (past): 6.8 out of ten. +31.4% a year over 10 filed years; profitable in 0 of 10. 67th percentile among 105 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Shareholder treatment (past): 6.9 out of ten. Share count grew 2.3% a year. 73% of cash flow returned. Insiders: 66 sales, 1 purchases. 69th percentile among 40 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Financial health (present): 4.9 out of ten. ROE -29%: lost 29¢ per shareholder dollar. Leverage 85%: owes 85¢ per asset dollar. 49th percentile among 120 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Industry position (present): 6.9 out of ten. top 31% of 109 in its family; net margin -6%. 69th percentile among 109 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Leadership (present): 4.7 out of ten. bottom 47% of 90 in its family for leadership; chief executive since 2021. 47th percentile among 90 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
  • Room to expand (future): 6.4 out of ten. top 36% of 104 in its family for room to expand. 64th percentile among 104 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Growth drivers (future): 6.3 out of ten. top 37% of 105 in its family for growth drivers. 63rd percentile among 105 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Expectations vs reality (future): 7.1 out of ten. top 29% of 88 in its family for expectations against reality. 71st percentile among 88 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).

The filing record

Newest annual report: Form 10-K filed 2026-02-19 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-06 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-06 for the period ended 2026-07-31 (on EDGAR). Newest filing: Form 8-K, 2026-10-05. Filings on record since 2007. Read from EDGAR 2026-10-12.

Where the revenue comes from

Product and service lines in fiscal 2025: Commercial Payors 53%, Centers for Medicare and Medicaid 24%, Healthcare Institutions 17%, Non Contracted Third Party Payors 7%. As tagged in its annual report (Form 10-K, filed 2026-02-19).

Who runs it

Blackford, Quentin S. (President and CEO); Wilson, Daniel G. (Chief Financial Officer); Patterson, Chad (CHIEF COMM & PRODUCT OFFICER); Shrishrimal, Sumi (EVP, Chief Risk Officer); Turakhia, Minang (CHIEF MED/SCI OFCR EVP ADVTECH); Rodda, Julianne (EVP, CHIEF PEOPLE OFFICER); Rosenbaum, Marc W. (Chief Accounting Officer); Lawrence, Brian Lee (Chief Technology Officer); Murphy, Patrick Michael (CBO and CLO); Smith, Mervin (EVP Strategic Business Ops); and 9 more. 19 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.

This file: Overview · Past · Present · Future · Filings · every company on file

Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.